Are you Dr. Molnar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
S Hawthorne Rd
Winston Salem, NC 27157Phone+1 336-716-2255
Summary
- Dr. Istvan Molnar, MD is an oncologist in Winston Salem, North Carolina. He is currently licensed to practice medicine in North Carolina.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2002
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 1995 - 1996
Huron HospitalResidency, Internal Medicine, 1992 - 1995
Semmelweis UniversityClass of 1991
Certifications & Licensure
NC State Medical License 2000 - 2016
Clinical Trials
- Cholecalciferol in Treating Patients With Myelodysplastic Syndrome Start of enrollment: 2003 Jul 01
- Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment Start of enrollment: 2003 May 01
- Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes Start of enrollment: 2004 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsThe Association Between Serum Copper and Anaemia in the Adult Second National Health and Nutrition Examination Survey (NHANES II) PopulationMary Ann Knovich, Dora Il'yasova, Anastasia Ivanova, Istvan Molnar
The British Journal of Nutrition. 2008-06-01 - 79 citationsPhiladelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.Yi-Kong Keung, Michael W. Beaty, Bayard L. Powell, Istvan Molnar, David H. Buss
Leukemia Research. 2004-06-01 - 3 citationsTreatment of post‐transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograftIstvan Molnar, Yi-Kong Keung
Nephrology, Dialysis, Transplantation. 2001-10-01
Press Mentions
Radionetics Oncology Appoints Istvan Molnar, M.D. As Chief Medical OfficerFebruary 22nd, 2023- Lantheus Announces Presentation Featuring AZEDRA® (Iobenguane I 131) at ENDO 2021March 22nd, 2021
- Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging AgentDecember 9th, 2020
- Join now to see all
